GEMIN4 and myeloid sarcoma: Among the combinations of genotypes, only the GA AGO1 and GA GEMIN4 heterozygotes showed a synergistic effect on the risk of MS (OR = 0.3714; 95% CI; 0.1720–0.8018; p = 0.0082).